(For Brucellosis in cattle)
markets the vaccine throughout Central and South America as well
as exclusive distribution rights for sub-Sahara Africa including South
Africa. Hertape, S.A., has manufacturing rights in Brazil.
PRONABIVE of Mexico, a quasi-governmental private company, to produce
and distribute in Mexico.
INDIAN IMMUNOLOGICAL LABORATORIES
Indian Immunological Laboratories and Vet Tech have a joint venture to manufacture and sell the vaccine in India.
CZU of Spain, to produce and
market throughout Europe, the Middle East and Northwest Africa and Russia.
The present brucellosis vaccine is manufacturered by Colorado
Serum in Denver, Colorado. VetTech in conjunction
Serum Co. is working with Malaysia and Indonesia to market the vaccine
in those countries and has opened a dialogue with China on introducing
the vaccine there.